Mester, P.;                     Keller, D.;                     Kunst, C.;                     Räth, U.;                     Rusch, S.;                     Schmid, S.;                     Krautbauer, S.;                     Müller, M.;                     Buechler, C.;                     Pavel, V.    
        High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19. Viruses 2024, 16, 1084.
    https://doi.org/10.3390/v16071084
    AMA Style
    
                                Mester P,                                 Keller D,                                 Kunst C,                                 Räth U,                                 Rusch S,                                 Schmid S,                                 Krautbauer S,                                 Müller M,                                 Buechler C,                                 Pavel V.        
                High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19. Viruses. 2024; 16(7):1084.
        https://doi.org/10.3390/v16071084
    
    Chicago/Turabian Style
    
                                Mester, Patricia,                                 Dennis Keller,                                 Claudia Kunst,                                 Ulrich Räth,                                 Sophia Rusch,                                 Stephan Schmid,                                 Sabrina Krautbauer,                                 Martina Müller,                                 Christa Buechler,                                 and Vlad Pavel.        
                2024. "High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19" Viruses 16, no. 7: 1084.
        https://doi.org/10.3390/v16071084
    
    APA Style
    
                                Mester, P.,                                 Keller, D.,                                 Kunst, C.,                                 Räth, U.,                                 Rusch, S.,                                 Schmid, S.,                                 Krautbauer, S.,                                 Müller, M.,                                 Buechler, C.,                                 & Pavel, V.        
        
        (2024). High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19. Viruses, 16(7), 1084.
        https://doi.org/10.3390/v16071084